intranasal glutathione in parkinson's disease Research progress on treatment for - Wen - 2024 - Neuroprotection Pharmacokinetics and pharmacodynamics of intranasally
Pharmacokinetics and pharmacodynamics of intranasally administered selegiline nanoparticles with improved brain delivery in Parkinson's disease ScienceDirect Intranasal Delivery of Metabolically Resilient Glutathione: In Vivo Pharmacokinetic, Permeation, and Efficacy Studies Molecular Pharmaceutics Revolutionizing Parkinson's treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy Drug Delivery and Translational Research Springer Nature Link Potential use of glutathione as a treatment for Parkinson's disease PMC
Pay in 4 interest-free payments of $7.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2



